Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
Neural retinal flicker response
Cat scratch symptoms
MS oral therapy
Female obesity and glaucoma
Biologics wet AMD treatment
Survey

Would you consider using operator-adjusted disc-definition for glaucoma detection?

Yes
80%
No
20%

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.

Click here to contact Neil Hanley, sales manager.

March 09, 2011
Neural retinal impairment linked to flicker light response
The impairment of vascular response to flicker lights could reveal inner retinal neural impairment in patients with diabetic retinopathy. More...
Unusual symptoms found in cat scratch disease patients
Vitreous haemorrhage with retinal vaculitis and isolated central retinal artery occlusion (CRAO) were reported in the eyes of patients with cat scratch disease. More...
Product Profiles
Croma
CORNEA_PROTECT® (2 % HPMC) guarantees protection and moisturization of the corneal surface during surgical procedures for up to 20 min. Also applications as a contact agent are possible.


Read more...
Product Profiles
Moria
For nearly two centuries, Moria has developed, manufactured, and distributed sophisticated, high quality, innovative ophthalmic surgical instrumentation and equipment that contribute to improved surgical outcomes.

Read more...
Potential oral therapy in MS
Oral resveratrol SRT501 significantly lowers neuronal damage, in a model of multiple scelrosis (MS). More...
Obesity in women descreases risk of glaucoma
Females with a higher body mass index (BMI) are less likely to develop open-angle glaucoma (OAG). More...
Biologics license applied for wet AMD treatment
A Biologics License Application (BLA) for VEGF Trap-Eye treatment of neovascular age-related AMD has been submitted to the US Food and Drug Administration (FDA) by Regeneron Pharmaceuticals. More...


You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH. United Kingdom